BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//pretalx//pretalx.com//sips2026-dc//talk//QENAYJ
BEGIN:VTIMEZONE
TZID:EST
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20061029T070000Z
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:STANDARD
DTSTART:20071104T030000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000402T030000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=4;UNTIL=20060402T080000Z
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20070311T030000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:pretalx-sips2026-dc-QENAYJ@pretalx.com
DTSTART;TZID=EST:20260609T110000
DTEND;TZID=EST:20260609T120000
DESCRIPTION:We will present information about the Patient-Centered Outcome 
 Research Institute (PCORI) and its Improving Methods for Conducting Patien
 t-Centered Comparative Clinical Effectiveness Research PCORI Funding Annou
 ncement (i.e.\, the Improving Methods PFA).\n\nThrough the Improving Metho
 ds PFA\, PCORI seeks to fund projects that address important methodologica
 l gaps and lead to improvements in the strength and quality of evidence ge
 nerated by patient-centered comparative effectiveness research studies.\n\
 nThe Improving Methods PFA has four priority areas:\n\n*Methods To Support
  the Use of Patient-Centered Measurement in Patient-Centered CER\n*Methods
  To Support the Use of Real-World Data (RWD) in Multi-Site Patient-Centere
 d CER\n*Methods To Improve the Use of Artificial Intelligence (AI) and Mac
 hine Learning (ML) in Patient-Centered CER\n*Methods To Improve Study Desi
 gn in Patient-Centered CER\n\nWe will answer questions about PCORI and the
  PFA
DTSTAMP:20260524T192111Z
LOCATION:WS Room 2418
SUMMARY:Information about the Improving Methods PCORI Funding Announcement 
 - Alex Uzdavines
URL:https://pretalx.com/sips2026-dc/talk/QENAYJ/
END:VEVENT
END:VCALENDAR